Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members

Journal of Neurochemistry

Volumn 78, Issue 6, 2001, Pages 1287-1296

  Gratacòs, Elena ^a   Pérez Navarro, Esther ^a   Tolosa, Eduard ^a   Arenas, Ernest ^b   Alberch, Jordi ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Grafting; Kainate; Protection; Striatal neurons

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALBINDIN; CHOLINE ACETYLTRANSFERASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; KAINIC ACID; NEUROTROPHIN; NEUROTROPHIN 3; NEURTURIN; PARVALBUMIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CORPUS STRIATUM; CYTOTOXICITY; DEGENERATIVE DISEASE; FEMALE; MALE; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELLS, CULTURED; CORPUS STRIATUM; DROSOPHILA PROTEINS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; INTERNEURONS; KAINIC ACID; MALE; MULTIGENE FAMILY; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES;

ANIMALIA;

EID: 0034811810     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00538.x     Document Type: Article

References (76)

1. Estimation of nuclear populations from microtome sections
2. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: Lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice
3. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons
4. Alternative excitotoxic hypotheses
5. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases
6. Role of Bcl-2 in the brain-derived neurotrophic factor survival response
7. Dopamine-induced protection of striatal neurons against kainate receptor-mediated glutamate cytotoxicity in vitro
8. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease
9. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid
10. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo
11. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo
12. 2+ influx
13. Cytoplasmic calcium buffer, calbindin-D28k, is regulated by excitatory amino acids
14. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
15. Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer
16. Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells
17. Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease
18. The neurotrophin receptors trkA, trkB and trkC are differentially regulated after excitotoxic lesion in rat striatum
19. Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area
20. Permissive role of interneurons in corticostriatal synaptic plasticity
21. Glutamate-mediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors
22. Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity
23. A consideration of neural counting methods
24. The role of neuronal growth factors in neurodegenerative disorders of the human brain
25. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea
26. Excitotoxic injury of the neostriatum: A model for Huntington's disease
27. GDNF induces the calretinin phenotype in cultures of embryonic striatal neurons
28. Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity
29. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat
30. Quinolinate and kainate neurotoxicity in neostriatal cultures is potentiated by co-culturing with neocortical neurons
31. Functional recovery in parkinsonian monkeys treated with GDNF
32. The neostriatal mosaic: Multiple levels of compartmental organization
33. Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons
34. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo
35. BDNF blocks caspase-3 activation in neonatal hypoxiaischemia
36. Role of neurotrophic factors in neuronal development
37. Cloned glutamate receptors
38. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons
39. Glial-cell-line-derived neurotrophic factor enhances biosynthesis of substance P in striatal neurons in vitro
40. Calbindin-D28K-containing neurons in animal models of neurodegeneration: Possible protection from excitotoxicity
41. Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease
42. Cellular delivery of trophic factors for the treatment of Huntington's disease: Is neuroprotection possible?
43. Early induction of mRNA for calbindin-D28k and BDNF but not NT-3 in rat hippocampus after kainic acid treatment
44. Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium-requiring intracellular signaling pathways
45. Excitatory amino acids as a final common pathway for neurologic disorders
46. Intrastriatal quinolinate or kainate injection differentially regulate GDNF, neurturin and their receptors in adult rat striatum
47. Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells
48. Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons
49. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids
50. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system
51. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons
52. Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28K
53. The effects of excitatory amino acids on intracellular calcium in single mouse striatal neurons in vitro
54. Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons
55. Neurotrophins promote the survival and development of neurons in the cerebellum of hypothyroid rats in vivo
56. Neurotrophins and basic fibroblast growth factor induce the differentiation of calbindin-containing neurons in the cerebral cortex
57. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage
58. Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo
59. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo
60. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease
61. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease
62. Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization
63. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum
64. Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum
65. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion
66. Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons
67. Postnatal development of calretinin- and parvalbumin-positive interneurons in the rat neostriatum: An immunohistochemical study
68. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvement of the glutathione system
69. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
70. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS
71. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro
72. 3H]aminobutyric acid from striatal neurons in primary culture
73. Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture
74. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
75. Topical application of neurotrophin-3 attenuates ischemic brain injury after transient middle cerebral artery occlusion in rats